Cargando…
The use of trastuzumab affected by health insurance policy in Jiangsu Province of China
BACKGROUND: Breast cancer recurrence and mortality have been shown to decrease after trastuzumab treatment in human epidermal growth factor 2 (HER2)-positive early-stage breast cancer (EBC) patients. In Jiangsu Province, trastuzumab has been subsidized for patients with HER2-positive EBC since 2013....
Autores principales: | Xia, Yiqin, Zheng, Mingjie, Zhan, Xiang, Liu, Ying, Cao, Susheng, Shao, Qing, Meng, Dong, Jin, Liyan, Xu, Lingyun, Yi, Tongbo, Xie, Hui, Wang, Shui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798405/ https://www.ncbi.nlm.nih.gov/pubmed/35116280 http://dx.doi.org/10.21037/tcr-20-3329 |
Ejemplares similares
-
Evaluating the Effectiveness of Regional Ecological Civilization Policy: Evidence from Jiangsu Province, China
por: Mi, Lingyun, et al.
Publicado: (2021) -
Why Not Blow the Whistle on Health Care Insurance Fraud? Evidence from Jiangsu Province, China
por: Wang, Dandan, et al.
Publicado: (2022) -
A Comparative Analysis of Impact of Universal Two-Child Policy on Maternity Insurance Fund in Jiangsu Province and Guangxi Zhuang AR
por: Asante Antwi, Henry, et al.
Publicado: (2021) -
Echovirus 30, Jiangsu Province, China
por: Zhao, Ya Nan, et al.
Publicado: (2005) -
Meteorological factors and tick density affect the dynamics of SFTS in jiangsu province, China
por: Deng, Bin, et al.
Publicado: (2022)